Psoriasis pustules disappear in over half of patients using Boehringer Ingelheim drug
More than half of patients treated for psoriasis with an intravenous injection showed no visible…
September 2, 2022 - 2 minutes
Boehringer Ingelheim
Three companies join forces to tackle antimicrobial resistance (AMR)
A joint venture to create the next generation of antimicrobials, along with actionable diagnostics to…
July 7, 2022 - 4 minutes
How Will We Be Treating Cystic Fibrosis 10 Years From Now?
Current treatments for cystic fibrosis are not suitable for all patients and have a limited…
November 22, 2021 - 9 minutes
ADC Approval Buoys Spirits in Cancer Treatment Space
The FDA recently approved an antibody-drug conjugate drug from ADC Therapeutics as a treatment for…
May 11, 2021 - 7 minutes
Boehringer Ingelheim Acquires Cancer Vaccine Biotech in €325M Deal
The German giant Boehringer Ingelheim has acquired the Swiss company AMAL Therapeutics and its cancer…
July 16, 2019 - 2 minutes
Boehringer Ingelheim Acquires Oncolytic Virus Biotech Company
Boehringer Ingelheim is paying €210M to acquire all the remaining shares of ViraTherapeutics, an Austrian…
September 13, 2018 - 2 minutes
Boehringer Offers €1Bn for New Checkpoint Inhibitor from a French Biotech
OSE Immunotherapeutics could receive up to €1.1Bn from its new partner Boehringer Ingelheim, which has…
April 5, 2018 - 2 minutes
No Nonsense Boehringer Ingelheim Jettisons Failing Alzheimer’s Disease Drug
Boehringer Ingelheim has ditched its Alzheimer's drug after it failed to meet the endpoints of…
February 12, 2018 - 3 minutes
Boehringer Ingelheim Doubles its Venture Fund for Exciting Biotech
Boehringer Ingelheim has committed to continue helping young companies grow by doubling the size of…
January 4, 2018 - 2 minutes
Schizophrenia and Drug Delivery Biotechs Sign a Major Pharma Partner
Santa Claus is not the only busy one in the weeks leading up to Christmas…
December 19, 2017 - 2 minutes
German Pharma and Biotech Gang Up on NASH in an Exciting Collaboration
Boehringer Ingelheim's fight against liver disease is taking shape, having agreed on a partnership with…
November 8, 2017 - 3 minutes
German Humira Biosimilar for Inflammatory Diseases Cleared for EMA Approval
Cyltezo, an adalimumab biosimilar drug by Boehringer Ingelheim, has received the backing to be marketed…
September 18, 2017 - 1 minute
